🇺🇸 FDA
Patent

US 8907060

Mutated Pseudomonas exotoxins with reduced antigenicity

granted A61KA61K38/00A61K47/6829

Quick answer

US patent 8907060 (Mutated Pseudomonas exotoxins with reduced antigenicity) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
105
CPC classes
A61K, A61K38/00, A61K47/6829, A61P, A61P35/00